179 related articles for article (PubMed ID: 8648376)
21. Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels.
Patt YZ; Podoloff DA; Curley S; Kasi L; Smith R; Bhadkamkar V; Charnsangavej C
J Clin Oncol; 1994 Mar; 12(3):489-95. PubMed ID: 8120546
[TBL] [Abstract][Full Text] [Related]
22. Localization of metastases from medullary thyroid carcinoma using different methods.
Cabezas RC; Berna L; Estorch M; Carrio I; Garcia-Ameijeiras A
Henry Ford Hosp Med J; 1989; 37(3-4):169-72. PubMed ID: 2639132
[TBL] [Abstract][Full Text] [Related]
23. Radioisotope-guided surgery in patients with pheochromocytoma and recurrent medullary thyroid carcinoma: a comparison of preoperative and intraoperative tumor localization with histopathologic findings.
Adams S; Acker P; Lorenz M; Staib-Sebler E; Hör G
Cancer; 2001 Jul; 92(2):263-70. PubMed ID: 11466678
[TBL] [Abstract][Full Text] [Related]
24. Functional nuclear medicine imaging of medullary thyroid cancer.
Bozkurt MF; Uğur O; Banti E; Grassetto G; Rubello D
Nucl Med Commun; 2008 Nov; 29(11):934-42. PubMed ID: 18836370
[TBL] [Abstract][Full Text] [Related]
25. Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer.
Kauhanen S; Schalin-Jäntti C; Seppänen M; Kajander S; Virtanen S; Schildt J; Lisinen I; Ahonen A; Heiskanen I; Väisänen M; Arola J; Korsoff P; Ebeling T; Sane T; Minn H; Välimäki MJ; Nuutila P
J Nucl Med; 2011 Dec; 52(12):1855-63. PubMed ID: 22052128
[TBL] [Abstract][Full Text] [Related]
26. Combined use of 111In-DTPA-D-Phe-1-octreotide (OCT) and 123I-vasoactive intestinal peptide (VIP) in the localization diagnosis of medullary thyroid carcinoma (MTC).
Kurtaran A; Leimer M; Kaserer K; Yang Q; Angelberger P; Niederle B; Virgolini I
Nucl Med Biol; 1996 May; 23(4):503-7. PubMed ID: 8832707
[TBL] [Abstract][Full Text] [Related]
27. Immunoscintigraphy in medullary thyroid cancer using an 123I- or 111In-labelled monoclonal anti-CEA antibody fragment.
Reiners C; Eilles C; Spiegel W; Becker W; Börner W
Nuklearmedizin; 1986 Dec; 25(6):227-31. PubMed ID: 3808964
[TBL] [Abstract][Full Text] [Related]
28. 18F-dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: relation to tumor differentiation.
Koopmans KP; de Groot JW; Plukker JT; de Vries EG; Kema IP; Sluiter WJ; Jager PL; Links TP
J Nucl Med; 2008 Apr; 49(4):524-31. PubMed ID: 18375923
[TBL] [Abstract][Full Text] [Related]
29. Radioimmunoimaging of metastatic medullary carcinoma of the thyroid gland using an indium-111-labeled monoclonal antibody to CEA.
Edington HD; Watson CG; Levine G; Tauxe WN; Yousem SA; Unger M; Kowal CD
Surgery; 1988 Dec; 104(6):1004-10. PubMed ID: 3194829
[TBL] [Abstract][Full Text] [Related]
30. Biodistribution and dosimetric study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent hapten.
Hosono M; Hosono MN; Kraeber-Bodéré F; Devys A; Thédrez P; Fiche M; Gautherot E; Barbet J; Chatal JF
J Nucl Med; 1998 Sep; 39(9):1608-13. PubMed ID: 9744353
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis of breast carcinoma with radiolabeled monoclonal antibodies (MoAbs) to carcinoembryonic antigen (CEA) and human milk fat globulin (HMFG).
Rosner D; Nabi H; Wild L; Ortman-Nabi J; Hreshchyshyn MM
Cancer Invest; 1995; 13(6):573-82. PubMed ID: 7583706
[TBL] [Abstract][Full Text] [Related]
32. Radioimmunoscintigraphy using iodine-131-anti-CEA monoclonal antibodies and thallium-201 scintigraphy in medullary thyroid carcinoma: a case report.
Zanin DE; van Dongen A; Hoefnagel CA; Bruning PF
J Nucl Med; 1990 Nov; 31(11):1854-5. PubMed ID: 2231001
[TBL] [Abstract][Full Text] [Related]
33. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
[TBL] [Abstract][Full Text] [Related]
34. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
[TBL] [Abstract][Full Text] [Related]
35. [Successful immunoscintigraphic tumor detection with technetium 99m marked monoclonal anti-CEA antibodies].
Baum RP; Lorenz M; Hertel A; Baew-Christow T; Schwarz A; Hör G
Onkologie; 1989 Aug; 12 Suppl 1():26-9. PubMed ID: 2685692
[TBL] [Abstract][Full Text] [Related]
36. A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy.
Stein R; Goldenberg DM
Mol Cancer Ther; 2004 Dec; 3(12):1559-64. PubMed ID: 15634649
[TBL] [Abstract][Full Text] [Related]
37. Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma.
Vuillez JP; Peltier P; Caravel JP; Chetanneau A; Saccavini JC; Chatal JF
J Clin Endocrinol Metab; 1992 Jan; 74(1):157-63. PubMed ID: 1727816
[TBL] [Abstract][Full Text] [Related]
38. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
[TBL] [Abstract][Full Text] [Related]
39. Preoperative localization of occult medullary carcinoma of the thyroid gland with single-photon emission tomography dimercaptosuccinic acid.
Udelsman R; Ball D; Baylin SB; Wong CY; Osterman FA; Sostre S
Surgery; 1993 Dec; 114(6):1083-9. PubMed ID: 8256211
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and therapeutic potential of new radiopharmaceutical agents in medullary thyroid carcinoma.
Troncone L; Rufini V; De Rosa G; Testa A
Henry Ford Hosp Med J; 1989; 37(3-4):178-84. PubMed ID: 2576959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]